Boardroom Alpha
Research library
Activism · Jun 25, 2026

CEA Industries Agrees to Add Three YZi Labs-Backed Directors Amid 92% Stock Collapse

CEA Industries Inc. (BNC) and YZi Labs Management Ltd. signed a cooperation agreement on June 23, 2026, expanding the board to six directors and immediately seating three YZi Labs-backed nominees — ending YZi Labs’ active campaign against the company. The…

CEA Industries Inc. (BNC) and YZi Labs Management Ltd. signed a cooperation agreement on June 23, 2026, expanding the board to six directors and immediately seating three YZi Labs-backed nominees — ending YZi Labs’ active campaign against the company. The deal arrives with BNC trailing the S&P 500 by 53 points on a three-year CAGR basis, and the stock down 92% from its August 2025 peak of $27.32.

BNC 5-Year Price

BNC 5-year price chart

1Y CAGR
-70.2%vs S&P +20.8% (-91.0pp)
3Y CAGR
-34.0%vs S&P +19.2% (-53.2pp)
Source: Boardroom Alpha · 13-F holdings via SEC filings

Under the agreement, CEA Industries’ board expands to six directors with the immediate appointment of Ling “Ella” Zhang, Alex Odagiu, and Matthew Roszak, each serving until the 2026 Special Meeting in lieu of annual meetings. The company must add a fourth mutually agreeable independent director within 90 days, and the board cannot grow beyond seven without YZi Labs’ written consent — though it may reach nine if a new CEO who is not already a director is brought on alongside a YZi Labs-recommended independent. Olshan Frome Wolosky represented YZi Labs, while Sidley Austin advised the company.

The governance reset comes after a severe destruction of shareholder value. BNC peaked at $27.32 on August 18, 2025, then collapsed 92% to a trough of $2.05 on June 8, 2026 — just two weeks before the agreement was signed. On a three-year CAGR basis, BNC has posted a loss of roughly 34% annually against the S&P 500’s 19% gain, a 53-point lag that forms the core of YZi Labs’ case for board-level intervention. YZi Labs entered the situation holding 2,150,481 shares of common stock plus 7,750,510 Pre-Funded Warrants and 9,900,991 Stapled Warrants, giving it substantial economic exposure to any recovery.

The agreement’s most operationally consequential provision is the CEO search mandate. Within three business days of signing, the board must form a five-member CEO Search Committee — chaired by Odagiu until a mutual independent director is seated — with a hard deadline of the earlier of the 2026 Annual Meeting or August 31, 2026. Candidates must have cryptocurrency experience, and YZi Labs’ suggestions, including Odagiu himself, must be considered. CEO appointment requires majority board approval plus sign-off from at least one YZi Labs director and one continuing director, giving both sides effective veto power over the hire. Until that appointment is made, Odagiu serves as Interim President reporting directly to the board, removable only for cause — a structural accountability mechanism that ties leadership continuity directly to the search timeline.

Cooperation Agreement Summary
Board Composition Board expanded to six; Zhang, Odagiu, and Roszak appointed immediately
Fourth Director Mutually agreeable independent director to be added within 90 days
Board Size Cap Cannot exceed seven directors without YZi Labs’ written consent
CEO Search Five-member CEO Search Committee formed within three business days; deadline August 31, 2026
Interim President Alex Odagiu serves as Interim President until new CEO is appointed
Standstill Runs until one month before the 2029 nomination deadline; broad acquisition and proxy restrictions
ShareXLinkedIn

Published Jun 25, 2026 · last updated Jun 25, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer